CN104815148B - A kind of pharmaceutical composition for treating the proliferation of mammary gland - Google Patents

A kind of pharmaceutical composition for treating the proliferation of mammary gland Download PDF

Info

Publication number
CN104815148B
CN104815148B CN201510200338.6A CN201510200338A CN104815148B CN 104815148 B CN104815148 B CN 104815148B CN 201510200338 A CN201510200338 A CN 201510200338A CN 104815148 B CN104815148 B CN 104815148B
Authority
CN
China
Prior art keywords
parts
radix
proliferation
mammary gland
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510200338.6A
Other languages
Chinese (zh)
Other versions
CN104815148A (en
Inventor
吴联合
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510200338.6A priority Critical patent/CN104815148B/en
Publication of CN104815148A publication Critical patent/CN104815148A/en
Application granted granted Critical
Publication of CN104815148B publication Critical patent/CN104815148B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of pharmaceutical compositions for treating the proliferation of mammary gland, include the bulk pharmaceutical chemicals of following parts by weight:30 45 parts of okra complete stool, 30 45 parts of Radix Astragali, 20 30 parts of blood clam, 20 30 parts of rhizoma cyperi, 18 25 parts of Radix Angelicae Sinensis, 18 25 parts of seaweed, 10 15 parts of the rhizome of davallia, 10 15 parts of radix bupleuri, 5 12 parts of Herba Epimedii, 5 12 parts of Semen Cuscutae, 38 parts of fritillaria thunbergii, 38 parts of Radix Salviae Miltiorrhizae, 38 parts of oryzanol, 38 parts of salvia chinensis.Unique formula of the invention, each bulk pharmaceutical chemicals collaboration work, and have the function of dispersing stagnated hepatoqi, blood circulation promoting and dispersing pathogen accumulation, resolving phlegm and softening hard masses, work to the proliferation of mammary gland quick, curative for effect.

Description

A kind of pharmaceutical composition for treating the proliferation of mammary gland
Technical field
The present invention relates to a kind of compositions, and in particular to a kind of pharmaceutical composition for treating the proliferation of mammary gland belongs to Chinese medicine skill Art field.
Background technology
The proliferation of mammary gland refers to breast epithelium and proliferation of fibrous tissue, the regression of breast tissue conduit and newborn leaflet in structure Venereal disease becomes and the growth of progressive connective tissue.It is the most common breast disease of women, pathogenic factor is mainly due to interior point Krinin dyssecretosis is related with mental element.Traditional Chinese Medicine think it be due to depressed rage impairing the liver, worry impairing spleen, qi stagnation blood stasis, Caused by phlegm congeals into core, Chong and Ren channel disorder, traditional Chinese medicine is referred to as " newborn addiction ".Modern medicine then thinks that its generation develops and lapsed to It is caused by the hormonal circadian variation in human female entirely.Spirit is excessively nervous, mood excessively excitement, the multiple stream of people, female Hormone absolutely or relatively increases, and progestational hormone is absolutely or relative reduction, long-term use health products, contraceptive etc. containing estrogen all may be used The proliferation of mammary gland can be caused.
Chinese medicine thinks, this sick pathogenic factor is mostly with internal organs dysfunction, qi-blood disharmony related, and women is sentimental, and one is not Satisfactory, the fire of conscience is sprung into life, and Liver Channel promoting lactation circulation two is coerced, and obstruction of the circulation of vital energy phlegm is caused to coagulate in breast.So Chinese medicine is generally adopted It is treated with the method for liver soothing and depression relief, promoting the circulation of qi resolving sputum.
Invention content
The object of the present invention is to provide a kind of pharmaceutical composition for treating the proliferation of mammary gland, the composition have dispersing stagnated hepatoqi, The effect of blood circulation promoting and dispersing pathogen accumulation, resolving phlegm and softening hard masses, can fast and effeciently prevent and treat the proliferation of mammary gland.
The present invention is achieved by the following measures:
A kind of pharmaceutical composition for treating the proliferation of mammary gland, it is characterized in that including the bulk pharmaceutical chemicals of following parts by weight:Okra is complete 30-45 parts of strain, 30-45 parts of Radix Astragali, 20-30 parts of blood clam, 20-30 parts of rhizoma cyperi, 18-25 parts of Radix Angelicae Sinensis, 18-25 parts of seaweed, bone is broken 10-15 parts of benefit, 10-15 parts of radix bupleuri, 5-12 parts of Herba Epimedii, 5-12 parts of Semen Cuscutae, 3-8 parts of fritillaria thunbergii, 3-8 parts of Radix Salviae Miltiorrhizae, oryzanol 3-8 parts, 3-8 parts of salvia chinensis.
Aforementioned pharmaceutical compositions preferably include the bulk pharmaceutical chemicals of following parts by weight:35 parts of okra complete stool, 35 parts of Radix Astragali, corrugation 25 parts of son, 25 parts of rhizoma cyperi, 20 parts of Radix Angelicae Sinensis, 20 parts of seaweed, 12 parts of the rhizome of davallia, 12 parts of radix bupleuri, 10 parts of Herba Epimedii, 10 parts of Semen Cuscutae, 5 parts of fritillaria thunbergii, 5 parts of Radix Salviae Miltiorrhizae, 5 parts of oryzanol, 5 parts of salvia chinensis.
The selected 14 taste medicinal material of the present invention is used as bulk pharmaceutical chemicals, and all medicines share is with dispersing stagnated hepatoqi, blood circulation promoting and dispersing pathogen accumulation, resolving phlegm and softening hard masses Effect, each bulk pharmaceutical chemicals effect are as follows:
Okra, alias gumbo(Scientific name:Abelmoschus esculentus), ambrette, foreign eggplant, goat's horn dish, swordweed, Goat's horn green pepper, foreign capsicum, are the annual herbaceous plant of Malvaceae.Okra complete stool includes root, leaf and fruit pod, rich in abundant Vitamin and trace element have the function of clearing heat and promoting diuresis, protection liver, strong kidney qi-restoratives, antifatigue.
Radix Astragali, legume astragalus mongolicus, Astragalus membranacus root, have invigorating qi for strengthening superficies, profit water detumescence, pus draining and toxin expelling, life Flesh and other effects.Nature and flavor are sweet, tepor, the diseases such as do not hold back long for spontaneous perspiration, night sweat, blood-arthralgia, edema, un-festering of ulcer or burst.
Blood clam, the shell of blood clam section animal chief blood clam, mud blood clam and blood clam, have dissolving phlegm softening hard masses, blood stasis-eliminating and stagnation-dissipating, relieving haperacidity analgesic Effect cures mainly chronic phlegm product knot, scrofula, goiter and tumor , abdominal mass and lump.
Rhizoma cyperi, the dry rhizome of sedge nutgrass flatsedge have the effect of promoting qi circulation and removing obstruction in the collateral, menstruction regulating and pain relieving, are used for liver depression gas It is stagnant, chest side of body, abdominal distention, indigestion, chest gastral cavity ruffian, cold hernia stomachache, swollen breasts, irregular menstruation, closed dysmenorrhea.
There is tonifying blood and regulating menstruation, promoting blood circulation and stopping pain to wither for the deficiency of blood the effect of relaxing bowel for Radix Angelicae Sinensis, the root of Umbelliferae Radix Angelicae Sinensis Huang, dizziness palpitaition, irregular menstruation, closed dysmenorrhea, asthenia cold abdominalgia, dry constipation of intestines, arthralgia pain due to rheumatism, injury from falling down, ulcer sores.
The drying frond of seaweed, Sargassaceae plant Sargassum or sargassum fusifome has softening and resolving hard mass, dissolving phlegm, the work(of Li Shui Effect is used for goiter and tumor, scrofula, testiclar gall, phlegm and retained fluid oedema.
The rhizome of davallia has the effect of The strong bone of kidney tonifying, continues and hinders pain relieving, is used for lumbago due to the kidney deficiency, Hiccough and deaf, and tooth mobility falls It winks and frustrates, injured bone.
The dry root of radix bupleuri, umbelliferae bupleurum or radix bupleuri scorzoneraefolii, have and inducing diaphoresis in, it is soothing the liver, the effect of rising Yang, use In cold, fever, fevers and chills alternate, distending pain in the chest and hypochondrium, irregular menstruation, sub-official prolapses, rectal prolapse.
Herba Epimedii, Berberidaceae plant Herba Epimedii, Epimedium sagittatum, E. Pubescens, E. wushanense T. S. Ying or korean epimedium herb Dry aerial parts, there is kidney-replenishing, the effect of strengthening the bones and muscles, wind-damp dispelling, be used for impotence and seminal emission, muscles and bones impotence, arthralgia pain due to rheumatism, Numbness contracture.
Semen Cuscutae, the seed of Convolvulaceae Semen Cuscutae have tonifying kidney and benefiting sperm, the effect of nourishing the liver to improve visual acuity, are suitable for kidney deficiency and liver Waist and knee muscles and bones ache, legs and feet are weak and feeble, impotence and seminal emission, crazy talk, frequent urination, dripping urination, it is dizzy, regard object not Clearly, Hiccough and deaf and women are under, the diseases such as habitual abortion.
Fritillaria thunbergii, the dry bulb of liliaceous plant fritillaria thunbergii have the effect of heat-clearing dissipating bind, preventing phlegm from forming and stopping coughing, are used for wind Heat violates lung, phlegm-fire cough, lung carbuncle, acute mastitis, scrofula, sore.
Radix Salviae Miltiorrhizae, the drying root and rhizome of labiate Radix Salviae Miltiorrhizae have stasis-dispelling and pain-killing, invigorate blood circulation, the work(of relieving restlessness that clears away heart-fire Effect is used for irregular menstruation, and closed dysmenorrhea, a lump in the abdomen causing distension and pain, chest and abdomen shouting pain, hot numbness pain, sore swell and ache curative, dysphoria and insomnia;Liver and spleen is swollen Greatly, angina pectoris.
Oryzanol has the effects that reduce blood fat, improves vegetative nerve function, sets the mind at rest, anxiety reduction, can be used for U.S. Hold, be also commonly used for premenstrual syndrome, menopausal syndrome auxiliary treatment.
Salvia chinensis, the herb of labiate Salvia chinensis have effects that promoting blood circulation and removing blood stasis, clearing heat and promoting diuresis, mass dissipating and swelling eliminating, Cure mainly irregular menstruation, dysmenorrhoea, Amenorrhea, uterine bleeding has blood in stool, treating rheumatic ostealgia, scrofula, sore swells, acute mastitis etc..
Present composition preparation method is simple, and each bulk pharmaceutical chemicals are uniformly mixed, and is ground into 80-100 targeted fine powders, i.e., It can.In order to convenient to take, can also capsule, tablets and other formulations be made using conventional method.
Pharmaceutical composition of the present invention 3 times a day, is calculated as 3-6g with bulk pharmaceutical chemicals every time when in use.
Unique formula of the invention, each bulk pharmaceutical chemicals collaboration work, and have the function of dispersing stagnated hepatoqi, blood circulation promoting and dispersing pathogen accumulation, resolving phlegm and softening hard masses, It works to the proliferation of mammary gland quick, it is curative for effect.
Specific implementation mode
The present invention is further detailed below by specific embodiment, following the description only plays illustrative work With not limiting its content.Unless otherwise instructed, following raw material medicaments are parts by weight.
Embodiment 1
Pharmaceutical formulation is as follows:35 parts of okra complete stool, 35 parts of Radix Astragali, 25 parts of blood clam, 25 parts of rhizoma cyperi, 20 parts of Radix Angelicae Sinensis, sea 20 parts of algae, 12 parts of the rhizome of davallia, 12 parts of radix bupleuri, 10 parts of Herba Epimedii, 10 parts of Semen Cuscutae, 5 parts of fritillaria thunbergii, 5 parts of Radix Salviae Miltiorrhizae, 5 parts of oryzanol, 5 parts of salvia chinensis.
Preparation method is:Each bulk pharmaceutical chemicals are uniformly mixed, be ground into 80-100 targeted fine powders to get.
Embodiment 2
Pharmaceutical formulation is as follows:30 parts of okra complete stool, 45 parts of Radix Astragali, 20 parts of blood clam, 30 parts of rhizoma cyperi, 18 parts of Radix Angelicae Sinensis, sea 25 parts of algae, 10 parts of the rhizome of davallia, 15 parts of radix bupleuri, 5 parts of Herba Epimedii, 12 parts of Semen Cuscutae, 3 parts of fritillaria thunbergii, 8 parts of Radix Salviae Miltiorrhizae, 3 parts of oryzanol, 8 parts of salvia chinensis.
The preparation method is the same as that of Example 1.
Embodiment 3
Pharmaceutical formulation is as follows:45 parts of okra complete stool, 30 parts of Radix Astragali, 30 parts of blood clam, 20 parts of rhizoma cyperi, 25 parts of Radix Angelicae Sinensis, sea 18 parts of algae, 15 parts of the rhizome of davallia, 10 parts of radix bupleuri, 12 parts of Herba Epimedii, 5 parts of Semen Cuscutae, 8 parts of fritillaria thunbergii, 3 parts of Radix Salviae Miltiorrhizae, 8 parts of oryzanol, 3 parts of salvia chinensis.
The preparation method is the same as that of Example 1.
Embodiment 4
Pharmaceutical formulation is as follows:30 parts of okra complete stool, 30 parts of Radix Astragali, 30 parts of blood clam, 30 parts of rhizoma cyperi, 18 parts of Radix Angelicae Sinensis, sea 18 parts of algae, 15 parts of the rhizome of davallia, 15 parts of radix bupleuri, 5 parts of Herba Epimedii, 5 parts of Semen Cuscutae, 8 parts of fritillaria thunbergii, 8 parts of Radix Salviae Miltiorrhizae, 3 parts of oryzanol, stone See and wears 5 parts.
The preparation method is the same as that of Example 1.
Embodiment 5
Pharmaceutical formulation is as follows:45 parts of okra complete stool, 45 parts of Radix Astragali, 20 parts of blood clam, 20 parts of rhizoma cyperi, 25 parts of Radix Angelicae Sinensis, sea 25 parts of algae, 10 parts of the rhizome of davallia, 10 parts of radix bupleuri, 12 parts of Herba Epimedii, 12 parts of Semen Cuscutae, 3 parts of fritillaria thunbergii, 3 parts of Radix Salviae Miltiorrhizae, 8 parts of oryzanol, 8 parts of salvia chinensis.
The preparation method is the same as that of Example 1.
Embodiment 6
Pharmaceutical formulation is as follows:45 parts of okra complete stool, 45 parts of Radix Astragali, 30 parts of blood clam, 30 parts of rhizoma cyperi, 25 parts of Radix Angelicae Sinensis, sea 18 parts of algae, 10 parts of the rhizome of davallia, 10 parts of radix bupleuri, 5 parts of Herba Epimedii, 5 parts of Semen Cuscutae, 3 parts of fritillaria thunbergii, 8 parts of Radix Salviae Miltiorrhizae, 8 parts of oryzanol, stone See and wears 3 parts.
The preparation method is the same as that of Example 1.
In the following, by partial clinical experiments have shown that the effect of drug of the present invention
1, patient source
The proliferation of mammary gland patient gone to a doctor in this city hospital outpatient is selected to be tested, totally 276,25 years old age~60 Year, average age 38.4 years old, patient have following at least one clinical symptoms:1)Unilateral or bilateral swollen breasts and secret anguish, the moon The pain increased when premenstrual and mood swing;2)Unilateral or bilateral differs in size, in the form of sheets, plate-like, graininess, streak, quality It is flexible, obscure boundary, with skin without adhesion, have the lump in breast of tenderness;3)Breast molybdenum target X-ray film is shown in more uniform increase in density Shadow.
, therapy
Above-mentioned patient is equally divided into 4 groups, no difference of science of statistics between each group is comparable, every group of 69 people.Each group is suffered from Person takes the drug of the embodiment of the present invention 1,2,3 and 5 respectively, and 3 times a day, each 5g, the menstrual period withdraws.
, criterion of therapeutical effect
It is effective:Lump in breast, pain completely disappear or breast pain obviously disappears, and lump major diameter reduces > 1/2;
Effectively:Lump in breast softens, and major diameter reduces > 1/3, while pain relief or disappearance;
In vain:Lump in breast major diameter is without diminution, and the symptoms such as pain are without significant change.
, treatment results
For each group patient continuous use after 2 months, treatment is as shown in the table:
Effective number Efficiently individual quantity Invalid number It is efficient
Embodiment 1 37 32 0 100%
Embodiment 2 23 39 7 89.9%
Embodiment 3 23 38 8 88.4%
Embodiment 5 27 38 4 94.2%

Claims (2)

1. a kind of pharmaceutical composition for treating the proliferation of mammary gland, it is characterized in that being made of the bulk pharmaceutical chemicals of following parts by weight:Okra is complete 30-45 parts of strain, 30-45 parts of Radix Astragali, 20-30 parts of blood clam, 20-30 parts of rhizoma cyperi, 18-25 parts of Radix Angelicae Sinensis, 18-25 parts of seaweed, bone is broken 10-15 parts of benefit, 10-15 parts of radix bupleuri, 5-12 parts of Herba Epimedii, 5-12 parts of Semen Cuscutae, 3-8 parts of fritillaria thunbergii, 3-8 parts of Radix Salviae Miltiorrhizae, oryzanol 3-8 parts, 3-8 parts of salvia chinensis.
2. pharmaceutical composition according to claim 1, it is characterized in that being made of the bulk pharmaceutical chemicals of following parts by weight:Okra is complete 35 parts of strain, 35 parts of Radix Astragali, 25 parts of blood clam, 25 parts of rhizoma cyperi, 20 parts of Radix Angelicae Sinensis, 20 parts of seaweed, 12 parts of the rhizome of davallia, 12 parts of radix bupleuri are excessive 10 parts of the sheep leaves of pulse plants, 10 parts of Semen Cuscutae, 5 parts of fritillaria thunbergii, 5 parts of Radix Salviae Miltiorrhizae, 5 parts of oryzanol, 5 parts of salvia chinensis.
CN201510200338.6A 2015-04-27 2015-04-27 A kind of pharmaceutical composition for treating the proliferation of mammary gland Expired - Fee Related CN104815148B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510200338.6A CN104815148B (en) 2015-04-27 2015-04-27 A kind of pharmaceutical composition for treating the proliferation of mammary gland

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510200338.6A CN104815148B (en) 2015-04-27 2015-04-27 A kind of pharmaceutical composition for treating the proliferation of mammary gland

Publications (2)

Publication Number Publication Date
CN104815148A CN104815148A (en) 2015-08-05
CN104815148B true CN104815148B (en) 2018-08-21

Family

ID=53725792

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510200338.6A Expired - Fee Related CN104815148B (en) 2015-04-27 2015-04-27 A kind of pharmaceutical composition for treating the proliferation of mammary gland

Country Status (1)

Country Link
CN (1) CN104815148B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1985939A (en) * 2005-12-19 2007-06-27 李文东 Tablet for treating mastosis and its preparing method
CN101002847A (en) * 2006-12-11 2007-07-25 三峡大学第一临床医学院 Medicine for treating mazoplasia, and its preparing method
CN101810744A (en) * 2009-12-11 2010-08-25 律北平 Formula of orally-taken Chinese medicament for treating hyperplasia of mammary glands
CN102178828A (en) * 2011-04-21 2011-09-14 安徽省药物研究所 Medicament for treating proliferation of mammary gland and preparation method thereof
CN103919984A (en) * 2014-05-10 2014-07-16 陈筠 Traditional Chinese medicine composition for treating mammary gland hyperplasia

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1985939A (en) * 2005-12-19 2007-06-27 李文东 Tablet for treating mastosis and its preparing method
CN101002847A (en) * 2006-12-11 2007-07-25 三峡大学第一临床医学院 Medicine for treating mazoplasia, and its preparing method
CN101810744A (en) * 2009-12-11 2010-08-25 律北平 Formula of orally-taken Chinese medicament for treating hyperplasia of mammary glands
CN102178828A (en) * 2011-04-21 2011-09-14 安徽省药物研究所 Medicament for treating proliferation of mammary gland and preparation method thereof
CN103919984A (en) * 2014-05-10 2014-07-16 陈筠 Traditional Chinese medicine composition for treating mammary gland hyperplasia

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
中药结合食疗治疗乳腺增生病疗效观察;胡艳聆等;《中国煤炭工业医学杂志》;20060228;第9卷(第02期);第199页 *
分型辨治乳腺增生病;阙华发等;《辽宁中医杂志》;19990618;第26卷(第06期);第259-260页 *
温阳活血汤治愈乳腺增生病2例;李金娥;《江西中医药》;19941230;第25卷;第54-55页 *

Also Published As

Publication number Publication date
CN104815148A (en) 2015-08-05

Similar Documents

Publication Publication Date Title
CN100558390C (en) A kind of unguentum of external curing arthralgia due to cold-dampnes
CN104667244B (en) A kind of Pediluvium composition for treating primary dysmenorrhea
CN104147514A (en) Chinese medicinal composition for treating cervical spondylosis and preparation method thereof
CN104623561A (en) Traditional Chinese medicine for treating hyperplasia of mammary glands
CN102698085B (en) Chinese medicinal plaster for treating arthritis
CN104547685A (en) Traditional Chinese medicine preparation for treating kidney stone and urinary stone
CN103083616B (en) Traditional Chinese medicine for treating ovarian cyst
CN102579750B (en) Traditional Chinese medicine composition for treating primary dysmenorrhea
CN104547736A (en) Medicine for treating goiter
CN104189268B (en) A kind of Chinese materia medica preparation for treating postpartum irregular menstruation
CN104815148B (en) A kind of pharmaceutical composition for treating the proliferation of mammary gland
CN104189824A (en) Traditional Chinese medicine preparation for treating cough and asthma of old people
CN103816522A (en) Chinese medicament for treating hyperplasia of mammary glands
CN104069447A (en) Traditional Chinese medicine preparation for treating ankylosing spondylitis
CN104001142A (en) Traditional Chinese medicine composition for treating wounds and bone fractures
CN104257898B (en) A kind of Chinese medicine preparation for treating postpartum irregular menstruation
CN103933455B (en) Traditional Chinese medicine for treating mammitis
CN100388946C (en) Plaster for treating orthopaedic diseases and its preparation process
CN106266704A (en) The Chinese medicine composition for the treatment of gastroenteritis and preparation method
CN106214831A (en) One treats leukodermic Chinese medicine for oral administration ball and preparation method thereof
CN106075160A (en) A kind of anti-tumor drug
CN105250961A (en) Medicine for treating hyperplasia of mammary glands
CN105963483A (en) Traditional Chinese medicine ointment for promoting fracture healing and preparation method thereof
CN104998219A (en) Medicament for treating vital-qi deficiency and blood stasis (kidney deficiency) type mammary gland hyperplasia
CN104436073A (en) Traditional Chinese medicine for treating hyperplasia of mammary glands

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180821

Termination date: 20190427

CF01 Termination of patent right due to non-payment of annual fee